Pfizer Inc
NYSE: PFE
$29.22
-$0.05 (-0.2%)
Closing Price on October 18, 2024
PFE Articles
Major Dow Jones Industrial Average companies in the health care sector saw a relatively strong 2016, with most posting a solid gain on the year.
Published:
Last Updated:
One strategy that has been quite common as investors rebalance and make changes each year is the Dogs of the Dow. Meet the 2017 Dogs of the Dow!
Published:
Last Updated:
The Dow has been within 1% of 20,000 for days now. What if the Dow actually manages to hit 22,000 in 2017? It may be far more possible than most investors might imagine.
Published:
Last Updated:
Most of the 30 components of the Dow Jones Industrial Average have risen by double-digit percentages this year. But these five stocks will keep the index from topping 20,000.
Published:
Last Updated:
The December 15 short interest data have been compared with the previous figures, and short interest increased in most of these selected pharmaceutical stocks.
Published:
Last Updated:
Dow 20,000 does not need all of the index's components to do well. However, these five could be a big enough drag to keep the index short of the number.
Published:
Last Updated:
December 21, 2016: Markets opened mixed Wednesday and the consensus opinion seems to be that traders are pausing to think about whether they really want the DJIA to top 20,000. It’s really just a...
Published:
Last Updated:
Portola Pharmaceuticals shares saw a handy gain on Monday after it was reported that the company had received a key loan.
Published:
Last Updated:
December 12, 2016: Markets opened mixed Monday as traders position themselves for the FOMC meeting announcement due on Wednesday. An early 4% spike in crude oil moderated later in the day, but oil...
Published:
Last Updated:
At the end of each year, investors look for opportunities and safe harbors to park their money for the year ahead. Investors who love dividends often consider the so-called Dogs of the Dow.
Published:
Last Updated:
The November 30 short interest data have been compared with the previous figures, and short interest decreased in these selected pharmaceutical stocks.
Published:
Last Updated:
With three weeks remaining in 2016, just four DJIA stocks are trading down for the year and all but one have a chance to turn positive by the end of the month. With the Dow hitting a new high...
Published:
Last Updated:
December 9, 2016: Markets opened higher again Friday with little support from either economic data or corporate earnings. One big positive came from the University of Michigan’s consumer sentiment...
Published:
Last Updated:
It turns out that 11 of the 30 Dow Jones Industrial Average stocks have a consensus price target that calls for more than 10% upside in the coming 12 months, and that is without considering dividends.
Published:
Last Updated:
With the top pharmaceutical stocks trailing the market by a large margin, they are starting to look very attractive for long-term growth and income investors.
Published:
Last Updated: